REGN vs SHW · P/E 14, rev $4.29B vs P/E 29, rev $12.46B
Regeneron Pharmaceuticals Inc (REGN) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the REGN and SHW stock pages for the full models.
Not investment advice.